Eurofins Scientific Valuation
| ERFSF Stock | USD 48.45 0.91 1.91% |
At this time, the firm appears to be overvalued. Eurofins Scientific shows a prevailing Real Value of $41.99 per share. The current price of the firm is $48.45. Our model computes the value of Eurofins Scientific from reviewing the firm fundamentals such as Current Valuation of 15.96 B, profit margin of 0.1 %, and Shares Outstanding of 192.56 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Eurofins Scientific's price fluctuation is very steady at this time. Calculation of the real value of Eurofins Scientific is based on 3 months time horizon. Increasing Eurofins Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Eurofins pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Eurofins Scientific SE. Since Eurofins Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eurofins Pink Sheet. However, Eurofins Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 48.45 | Real 41.99 | Hype 48.45 | Naive 46.59 |
The real value of Eurofins Pink Sheet, also known as its intrinsic value, is the underlying worth of Eurofins Scientific Company, which is reflected in its stock price. It is based on Eurofins Scientific's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Eurofins Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Eurofins Scientific SE helps investors to forecast how Eurofins pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eurofins Scientific more accurately as focusing exclusively on Eurofins Scientific's fundamentals will not take into account other important factors: Eurofins Scientific Total Value Analysis
Eurofins Scientific SE is currently projected to have takeover price of 15.96 B with market capitalization of 13.82 B, debt of 2.08 B, and cash on hands of 718.8 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Eurofins Scientific fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.96 B | 13.82 B | 2.08 B | 718.8 M |
Eurofins Scientific Investor Information
About 33.0% of the company shares are held by company insiders. The book value of Eurofins Scientific was currently reported as 24.42. The company last dividend was issued on the 5th of July 2022. Eurofins Scientific had 10:1 split on the 19th of November 2020. Based on the measurements of operating efficiency obtained from Eurofins Scientific's historical financial statements, Eurofins Scientific SE is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Eurofins Scientific Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Eurofins Scientific has an asset utilization ratio of 71.98 percent. This implies that the Company is making $0.72 for each dollar of assets. An increasing asset utilization means that Eurofins Scientific SE is more efficient with each dollar of assets it utilizes for everyday operations.Eurofins Scientific Ownership Allocation
Eurofins Scientific holds a total of 192.56 Million outstanding shares. Eurofins Scientific SE retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Eurofins Scientific Profitability Analysis
The company reported the revenue of 6.72 B. Net Income was 782.6 M with profit before overhead, payroll, taxes, and interest of 1.91 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Eurofins Scientific's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Eurofins Scientific and how it compares across the competition.
About Eurofins Scientific Valuation
The pink sheet valuation mechanism determines Eurofins Scientific's current worth on a weekly basis. Our valuation model uses a comparative analysis of Eurofins Scientific. We calculate exposure to Eurofins Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eurofins Scientific's related companies.Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. Eurofins Scientific operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 61000 people.
8 Steps to conduct Eurofins Scientific's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Eurofins Scientific's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Eurofins Scientific's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Eurofins Scientific's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Eurofins Scientific's revenue streams: Identify Eurofins Scientific's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Eurofins Scientific's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Eurofins Scientific's growth potential: Evaluate Eurofins Scientific's management, business model, and growth potential.
- Determine Eurofins Scientific's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Eurofins Scientific's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Eurofins Scientific Growth Indicators
Investing in growth stocks can be very risky. If the company such as Eurofins Scientific does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 192.3 M | |
| Quarterly Earnings Growth Y O Y | -0.265 | |
| Forward Price Earnings | 17.1527 | |
| Retained Earnings | 2 B |
Complementary Tools for Eurofins Pink Sheet analysis
When running Eurofins Scientific's price analysis, check to measure Eurofins Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Scientific is operating at the current time. Most of Eurofins Scientific's value examination focuses on studying past and present price action to predict the probability of Eurofins Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Scientific's price. Additionally, you may evaluate how the addition of Eurofins Scientific to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance |